According to the latest data from the Centers for Disease Control, the current bird flu outbreak has caused 67 human cases of bird flu in the U.S. and one death associated with the virus.

The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country doubles down on efforts to tackle increasing infections in humans.

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an mRNA-based bird flu vaccine, health officials said.

The funding, which follows the $176 million the government awarded Moderna in June 2024, aims to get mRNA vaccines ready before bird flu strains currently circulating in the wild and on farms can potentially cause human outbreaks.

Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S. Department of Health and Human Services (HHS) to accelerate the development of mRNA-based pandemic influenza vaccines. The award was made

Earlier this month, Moderna announced business updates and progress across its pipeline. Moderna says it enters 2025 with a focus on a prioritized portfolio addressing respiratory viruses, rare diseases, oncology, and latent and other viruses. Price Action: MRNA stock is up 5.75% at $36.02 at last check Tuesday.

The Department of Health and Human Services (HHS) will award roughly $590 million to Moderna to accelerate the development of mRNA-based pandemic influenza vaccines, including vaccines for avian flu strains, to ensure the United States is better prepared for future potential pandemics, according to a recent HHS news release.

No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even probable.

The U.S. Department of Health and Human Services (HHS) has announced $590 million in funding to Moderna to expedite the development of mRNA-based vaccines aimed at combating

As avian flu outbreaks continue to hit US poultry farm s and backyard flocks, the US Department of Agriculture (USDA) Animal and Plant Health Inspection Service (APHIS) confirmed more H5N1 detections in five states, including a second commercial chicken farm in Georgia, the nation's top broiler-producing state.

"The Chinese poultry lineage may have experienced more vaccine-driven selection compared to other lineages," the researchers wrote.